bioAffinity Technologies (BIAF) Payables (2021 - 2026)

bioAffinity Technologies has disclosed Payables across 6 years of filings, most recently posting $897352.0 for Q1 2026.

• In Q1 2026, Payables fell 39.63% year-over-year to $897352.0; the TTM figure through Mar 2026 stood at $897352.0 (down 39.63% YoY), while the FY2025 annual figure was $867062.0, down 25.19% from the prior year.
• Payables advanced to $897352.0 in Q1 2026, from $867062.0 in the prior quarter.
• Over the last five years, Payables for BIAF reached as high as $1.5 million in Q1 2025 and fell as low as $146537.0 in Q1 2023.
• The 5-year median for Payables is $852208.0 (2024), against an average of $770241.9.
• Annual changes were most pronounced in 2022 — Payables plunged 96.97% — and 2024, when it soared 388.64%.
• A 5-year view of Payables shows it stood at $345042.0 in 2022, then soared by 75.28% to $604789.0 in 2023, then surged by 91.63% to $1.2 million in 2024, then fell by 25.19% to $867062.0 in 2025, then climbed by 3.49% to $897352.0 in 2026.
• According to Business Quant data, Payables over the past three periods registered $897352.0, $867062.0, and $1.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.